U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07168772) titled 'The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis' on Aug. 26.
Brief Summary: It is a randomized, double-blind, placebo-controlled clinical trial whose general objective of this study is to determine the effects of probiotic administration in multiple sclerosis patients.
80 patients with relapsing-remitting multiple sclerosis will be enrolled in the study. Patients will be randomly assigned to receive either a probiotic (n=40) or a placebo (n=40) stratified by type of medication, gender and use of hormonal contraceptive treatment. They will receive a probiotic (Lactibane Iki) or placebo sachet t...